Under fasting conditions, TXNIP suppresses glucose uptake directly by binding to the glucose transporters GLUT1 and GLUT4 and by inducing GLUTs endocytosis, in order to prevent hypoglycemia (Waldhart et al., 2017; Wu et al., 2013). This evidence concerns the gene SLC2A4 and Hypoglycemia.